Hanson & Doremus Investment Management continued to hold its position in CME Group Inc. (NASDAQ:CME) during the second quarter, Holdings Channel reports. The institutional investor owned 4,530 shares of the company’s stock at the end of the second quarter. Hanson & Doremus Investment Management’s holdings in CME Group were worth $441,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Bbva Compass Bancshares Inc. purchased a new position in CME Group during the second quarter valued at about $262,000. Glenview State Bank Trust DEPT. boosted its stake in shares of CME Group by 0.7% in the second quarter. Glenview State Bank Trust DEPT. now owns 35,012 shares of the company’s stock valued at $3,410,000 after buying an additional 254 shares during the last quarter. Manitou Investment Management Ltd. boosted its stake in shares of CME Group by 33.8% in the second quarter. Manitou Investment Management Ltd. now owns 166,221 shares of the company’s stock valued at $16,190,000 after buying an additional 42,010 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in shares of CME Group by 4.6% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,137,234 shares of the company’s stock valued at $110,767,000 after buying an additional 50,334 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC bought a new stake in shares of CME Group during the second quarter valued at approximately $1,027,000. 79.89% of the stock is owned by institutional investors.
CME Group Inc. (NASDAQ:CME) traded down 1.58% during midday trading on Monday, reaching $103.77. The company had a trading volume of 386,966 shares. The stock has a market capitalization of $35.16 billion, a PE ratio of 26.20 and a beta of 0.83. CME Group Inc. has a 12-month low of $81.87 and a 12-month high of $110.35. The company has a 50-day moving average of $106.48 and a 200-day moving average of $99.70.
CME Group (NASDAQ:CME) last posted its earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm had revenue of $906 million for the quarter, compared to analysts’ expectations of $897.84 million. During the same period in the previous year, the firm earned $0.95 earnings per share. The business’s revenue was up 10.5% compared to the same quarter last year. On average, analysts predict that CME Group Inc. will post $4.43 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Monday, September 26th. Stockholders of record on Friday, September 9th were paid a dividend of $0.60 per share. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.29%. CME Group’s dividend payout ratio (DPR) is presently 60.61%.
Several analysts recently commented on the company. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $116.00 target price on the stock in a report on Thursday, August 4th. Jefferies Group increased their price target on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a report on Wednesday, August 31st. Barclays PLC cut their price target on CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a report on Friday, July 29th. JPMorgan Chase & Co. set a $116.00 price target on CME Group and gave the stock a “buy” rating in a report on Monday, September 12th. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a report on Friday, July 29th. Two analysts have rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $103.27.
In related news, insider Hilda Harris Piell sold 893 shares of CME Group stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $110.00, for a total transaction of $98,230.00. Following the sale, the insider now directly owns 29,125 shares in the company, valued at $3,203,750. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Bryan T. Durkin sold 15,000 shares of CME Group stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $107.75, for a total value of $1,616,250.00. Following the sale, the insider now owns 63,967 shares in the company, valued at $6,892,444.25. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.